Detalhe da pesquisa
1.
Health-related quality of life decline in clinically stable inflammatory bowel disease patients during the COVID-19 outbreak.
Rev Esp Enferm Dig
; 115(6): 315-319, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297257
2.
Severe and refractory gastrointestinal toxicity due to immune checkpoint inhibitors: clinical experience in a tertiary referral hospital.
Rev Esp Enferm Dig
; 115(10): 567-573, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37170542
3.
Normalization of long-term quality of life in Crohn's disease patients receiving ustekinumab.
Rev Esp Enferm Dig
; 113(5): 313-317, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33213168
4.
Impact of the COVID-19 pandemic on the activity of advanced-practice nurses on a reference unit for inflammatory bowel disease.
Gastroenterol Hepatol
; 44(7): 481-488, 2021.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-33515625
5.
Effectiveness of a Telephone-Based Motivational Intervention for Smoking Cessation in Patients With Crohn Disease: A Randomized, Open-Label, Controlled Clinical Trial.
Gastroenterol Nurs
; 44(6): 418-425, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34269705
6.
Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment.
Nutrients
; 13(6)2021 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34067320
7.
Leishmania infantum asymptomatic infection in inflammatory bowel disease patients under anti-TNF therapy.
Heliyon
; 6(5): e03940, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32420499
8.
Patient preferences for inflammatory bowel disease treatment objectives.
Dig Liver Dis
; 49(2): 152-156, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717791